Characterization of [ 18 F]PF-NB1 Enantiomers for Imaging NMDA GluN2B Receptors in Nonhuman Primates and Comparison with Analogous 18 F-labeled Radiotracers
ACS Chemical Neuroscience · 2026
DOI: 10.1021/acschemneuro.5c00840 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift ACS Chemical Neuroscience, 2026. Verfasst von Santosh R Alluri und 8 weiteren Autor:innen. Beteiligte Einrichtung: PET Center, Yale University, New Haven, Connecticut 06519, United States. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate, Fluorine Radioisotopes, Positron-Emission Tomography, Brain. Die Arbeit nennt 25 Literaturangaben. Gefördert von: NIMH NIH HHS, National Institute of Mental Health.
Abstract (Originalsprache)
The GluN2B subunit of N-methyl-d-aspartate receptors (NMDARs) plays a key role in regulating excitatory neurotransmission and synaptic plasticity. Aberrant GluN2B signaling contributes to glutamate-mediated excitotoxicity and has been implicated in neurodegenerative and neuropsychiatric disorders, making it a crucial target for therapeutic development and in vivo imaging. In this study, we systematically evaluated the pharmacokinetics and imaging characteristics of both (R)- and (S)-enantiomers of [18F]PF-NB1 PET tracers in nonhuman primates to determine their suitability for clinical translation. Dynamic PET scans, arterial input functions, kinetic modeling, and blocking studies were performed to assess brain uptake, regional distribution consistent with GluN2B expression, binding specificity, and metabolite profiles. In addition to direct comparison of the two enantiomers, we benchmarked their in vivo performance against analogous 18F-labeled GluN2B tracers, including OF-Me-NB1 and OF-NB1. This cross-evaluation revealed differences in brain uptake, regional distribution matching GluN2B expression, binding specificity, and metabolic stability. Regional time-activity curves were fitted with the one-tissue compartment (1TC) model to derive regional volume of distribution (VT) values, which were higher for (R)-[18F]PF-NB1(61.5-169.4 mL/cm3) than (S)-[18F]PF-NB1 (48.6-88.9 mL/cm3) in the same monkey. A GluN2B selective antagonist, Co-101,244, substantially reduced the uptake and VT values of both (R)- and (S)-[18F]PF-NB1 across brain regions, with calculated target occupancy of 96% and 90%, and nondisplaceable volume of distribution (VND, mL/cm3) values of 10.01 and 11.45, respectively. In the same monkey, regional nondisplaceable binding potential (BPND) values ranged from 3.24 to 6.76 for (S)-[18F]PF-NB1, and from 5.12 to 15.92 for (R)-[18F]PF-NB1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PET Center, Yale University, New Haven, Connecticut 06519, United States.
- Institute of Pharmaceutical Sciences, ETH Zurich, Zurich 8092, Switzerland.
ORCID-Profile: Santosh R Alluri
Förderung
- NIMH NIH HHS
- National Institute of Mental Health
Zitieren
APA
Alluri, S. R., Zheng, M. Q., Holden, D., Ahmed, H., Felchner, Z., Kapinos, M., Carson, R. E., Ametamey, S. M., & Huang, Y. (2026). Characterization of [ 18 F]PF-NB1 Enantiomers for Imaging NMDA GluN2B Receptors in Nonhuman Primates and Comparison with Analogous 18 F-labeled Radiotracers. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00840
Vancouver
Alluri SR, Zheng MQ, Holden D, Ahmed H, Felchner Z, Kapinos M, et al. Characterization of [ 18 F]PF-NB1 Enantiomers for Imaging NMDA GluN2B Receptors in Nonhuman Primates and Comparison with Analogous 18 F-labeled Radiotracers. ACS Chemical Neuroscience. 2026. doi:10.1021/acschemneuro.5c00840
BibTeX
@article{Alluri2026,
author = {Alluri, Santosh R and Zheng, Ming-Qiang and Holden, Daniel and Ahmed, Hazem and Felchner, Zachary and Kapinos, Michael and Carson, Richard E and Ametamey, Simon M and Huang, Yiyun},
title = {Characterization of [ 18 F]PF-NB1 Enantiomers for Imaging NMDA GluN2B Receptors in Nonhuman Primates and Comparison with Analogous 18 F-labeled Radiotracers},
journal = {ACS Chemical Neuroscience},
year = {2026},
doi = {10.1021/acschemneuro.5c00840}
}
EUVIMED